the Broad Institute

Universities Are Arguing Over Genome Editing Technology, But What Does The Law Have to Say About It?

Three major universities are now engaged in a patent lawsuit to protect their rights to use genome editing technology called CRISPR-Cas9. The fallout will have far more impact than the simple settling of ownership and intellectual property rights, however; experts believe that CRISPR-Cas9 may be the most efficient route toward a ticking off items on a laundry list of amazing biotechnological discoveries.
Real Time Analytics